HW
Hugues Wallemacq
Chief Executive Officer at EXO Biologics
Liège, Walloon Region
Overview
Hugues Wallemacq is the CEO of EXO Biologics Group, with a background in lifesciences, molecular biology, and biotechnology. His career highlights include leading EXO Biologics as CEO and COO, as well as serving in key roles at GSK and Unisensor, showcasing expertise in the pharmaceutical industry and immunology.
Hugues Wallemacq's professional profile is distinguished by his executive leadership at EXO Biologics and his prior roles at GSK, where he served as Director of Clinical Immuno-Chemistry Assays and Preclinical Leader.
Work Experience
Chief Executive Officer
2022 - Current
Chief Operations Officer
2021 - 2022
Investment Manager
2020
Board Member
2020 - 2022
Head of Business Development
2020 - 2021
Director Research and Development
2016 - 2020
Director Clinical Immuno-Chemistry Assays
2013 - 2016
Preclinical leader
2010 - 2013
PhD Immunology
2006 - 2010
PhD performed at GIGA I3 in the lab of Pr Fabrice Bureau (Molecular and cellular immunology).
Veterinarian
2003 - 2006